|
Volumn 14, Issue 18, 2000, Pages 2913-2920
|
Combination antiretroviral therapy and duration of pregnancy
a a a a a a a a a a a a a a a a a a a a more.. |
Author keywords
Antiretroviral therapy; Combination therapy; Epidemiology; Pregnancy; Prematurity
|
Indexed keywords
ANTIRETROVIRUS AGENT;
PROTEINASE INHIBITOR;
ZIDOVUDINE;
ADULT;
ARTICLE;
CESAREAN SECTION;
CONTROLLED STUDY;
DISEASE ASSOCIATION;
EUROPE;
FEMALE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IMMUNE DEFICIENCY;
INFANT;
LYMPHOCYTE COUNT;
MAJOR CLINICAL STUDY;
MALE;
MULTIVARIATE ANALYSIS;
PREGNANCY;
PREMATURITY;
PRIORITY JOURNAL;
RISK ASSESSMENT;
VERTICAL TRANSMISSION;
VIRUS LOAD;
VIRUS TRANSMISSION;
ADULT;
ANTI-HIV AGENTS;
CD4 LYMPHOCYTE COUNT;
COHORT STUDIES;
DELIVERY, OBSTETRIC;
DRUG THERAPY, COMBINATION;
FEMALE;
GESTATIONAL AGE;
HIV INFECTIONS;
HIV-1;
HUMANS;
INFANT, NEWBORN;
INFANT, PREMATURE;
PREGNANCY;
PREGNANCY COMPLICATIONS, INFECTIOUS;
PREGNANCY OUTCOME;
PROSPECTIVE STUDIES;
REVERSE TRANSCRIPTASE INHIBITORS;
SUBSTANCE ABUSE, INTRAVENOUS;
VIRAL LOAD;
ZIDOVUDINE;
|
EID: 0034526376
PISSN: 02699370
EISSN: None
Source Type: Journal
DOI: 10.1097/00002030-200012220-00013 Document Type: Article |
Times cited : (244)
|
References (24)
|